Drugs

Centering on the Updated Schedule M within the Drugs and Cosmetics Act of 1940, the Central Drug Research Institute (CDRI) located in Lucknow, Uttar Pradesh, will conduct an industry conclave featuring panel discussions on November 23. Invitations are extended to […]

The Indian Institute of Science (IISc) has joined forces with University College London (UCL) in a fresh strategic partnership aimed at promoting joint initiatives in healthcare advancement. This partnership was preceded by a letter of intent aimed at fostering closer

Boehringer Ingelheim India, as part of its Angels Initiative, has partnered with RED.Health to formalize efforts aimed at elevating stroke care in pre-hospital scenarios across India. This alliance highlights a mutual dedication to improving emergency healthcare services and facilitating prompt

Oxford-based SynaptixBio is advancing the development of an antisense oligonucleotide (ASO) aimed at inhibiting the expression of a single mutated gene. The company has identified a significant growth trajectory in the gene silencing market, driven by the advantages it offers

 In a spectacular event celebrating excellence in vision care, the 2024 Super Specialty Lens Symposium took place in Mumbai, showcasing outstanding contributions in ophthalmology and optometry with the esteemed Dr. B T Maskati Memorial Awards. The

360 ONE Asset, a prominent asset management company in India, has invested in OneSource Specialty Pharma, a rapidly expanding and specialized pharma CDMO (contract development and manufacturing organization). This strategic acquisition involved purchasing a stake from an existing investor, aligning

Abbott, known worldwide for its healthcare innovation, has introduced the AVEIR VR ventricular leadless pacemaker in India, targeting patients with bradycardia. The device has secured approval from both the Central Drugs Standard Control Organization (CDSCO) in India and the US

The Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), a cornerstone of the government medical structure in southern India, draws a substantial number of patients from nearby states. In response to the growing health issue, specialist teams at JIPMER

The International Pharmaceutical Federation (FIP) emphasizes the importance of strategic actions that pharmacists need to undertake in order to combat antimicrobial resistance (AMR). In a recent release, FIP introduces six dedicated “AMR strategies,” tailored for each World Health Organization region,

argenx SE, a global leader in immunology focused on enhancing the lives of those with severe autoimmune conditions, revealed their commitment to advancing efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in the ongoing phase 2/3 ALKIVIA trial for adults with